Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy
- PMID: 20201891
- PMCID: PMC5941943
- DOI: 10.1111/j.1749-6632.2009.05088.x
Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy
Abstract
Cardiac hypertrophy results from increased mechanical load on the heart and through the action of neurohumoral mediators. ERK1/2 are known to be activated in response to almost every stress- and agonist-induced hypertrophic stimulus examined to date, suggesting the straightforward hypothesis that these kinases are required for promoting the cardiac growth response. However, recent data from genetically modified mouse models suggest a more complicated picture. For example, inducible expression of dual-specificity phosphatase 6, an ERK1/2-inactivating phosphatase, eliminated ERK1/2 phosphorylation in transgenic mice, but it did not diminish the hypertrophic response to pressure overload. Similarly, Erk1-/- and Erk2+/- mice showed no reduction in stimulus-induced cardiac growth in vivo. However, blockade or deletion of cardiac ERK1/2 did predispose the heart to decompensation and failure after long-term pressure overload. Thus, ERK1/2 signaling is not to be absolutely necessary for mediating cardiac hypertrophy, although it does appear to provide critical protective effects/signals during stress-stimulation.
Figures


Similar articles
-
Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14074-9. doi: 10.1073/pnas.0610906104. Epub 2007 Aug 20. Proc Natl Acad Sci U S A. 2007. PMID: 17709754 Free PMC article.
-
A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy.Nat Med. 2009 Jan;15(1):75-83. doi: 10.1038/nm.1893. Epub 2008 Dec 7. Nat Med. 2009. PMID: 19060905
-
Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.J Mol Cell Cardiol. 2014 Jul;72(100):104-16. doi: 10.1016/j.yjmcc.2014.03.002. Epub 2014 Mar 12. J Mol Cell Cardiol. 2014. PMID: 24631771 Free PMC article.
-
Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.Hypertension. 2016 Jan;67(1):86-98. doi: 10.1161/HYPERTENSIONAHA.115.05957. Epub 2015 Nov 16. Hypertension. 2016. PMID: 26573707 Review.
-
Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.Circ Res. 2002 Nov 1;91(9):776-81. doi: 10.1161/01.res.0000038488.38975.1a. Circ Res. 2002. PMID: 12411391 Review.
Cited by
-
Different roles of the cardiac Na+/Ca2+-exchanger in ouabain-induced inotropy, cell signaling, and hypertrophy.Am J Physiol Heart Circ Physiol. 2013 Feb 1;304(3):H427-35. doi: 10.1152/ajpheart.00462.2012. Epub 2012 Nov 30. Am J Physiol Heart Circ Physiol. 2013. PMID: 23203972 Free PMC article.
-
Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophy.Front Pharmacol. 2015 Jul 24;6:149. doi: 10.3389/fphar.2015.00149. eCollection 2015. Front Pharmacol. 2015. PMID: 26257652 Free PMC article. Review.
-
Inhibition of mTOR or MAPK ameliorates vmhcl/myh7 cardiomyopathy in zebrafish.JCI Insight. 2021 Dec 22;6(24):e154215. doi: 10.1172/jci.insight.154215. JCI Insight. 2021. PMID: 34935644 Free PMC article.
-
Key role of ERK1/2 molecular scaffolds in heart pathology.Cell Mol Life Sci. 2013 Nov;70(21):4047-54. doi: 10.1007/s00018-013-1321-5. Epub 2013 Mar 27. Cell Mol Life Sci. 2013. PMID: 23532408 Free PMC article. Review.
-
The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth.Br J Pharmacol. 2013 Jan;168(2):296-317. doi: 10.1111/j.1476-5381.2012.02195.x. Br J Pharmacol. 2013. PMID: 22946456 Free PMC article. Review.
References
-
- HO KK, PINSKY JL, KANNEL WB, LEVY D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22:6A–13A. - PubMed
-
- KLEIN L, et al. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am J Cardiol. 2003;91:18F–40F. - PubMed
-
- BUENO OF, MOLKENTIN JD. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res. 2002;91:776–81. - PubMed
-
- GARRINGTON TP, JOHNSON GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol. 1999;11:211–8. - PubMed
-
- WELLBROCK C, KARASARIDES M, MARAIS R. The RAF proteins take centre stage. Nat Rev Mol Cell Biol. 2004;5:875–85. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous